In this multicenter prospective followup study , a cohort of 195 patients with early , clinically active RA was randomly assigned to treatment with a combination of methotrexate , sulfasalazine , hydroxychloroquine , and prednisolone or with a single DMARD ( initially , sulfasalazine ) with or without prednisolone .
